X-38073655-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138780.3(SYTL5):c.511G>A(p.Val171Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000561 in 1,087,639 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138780.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYTL5 | NM_138780.3 | c.511G>A | p.Val171Ile | missense_variant | 5/17 | ENST00000297875.7 | NP_620135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYTL5 | ENST00000297875.7 | c.511G>A | p.Val171Ile | missense_variant | 5/17 | 5 | NM_138780.3 | ENSP00000297875 | P4 | |
SYTL5 | ENST00000456733.2 | c.511G>A | p.Val171Ile | missense_variant | 4/17 | 1 | ENSP00000395220 | A1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.0000186 AC: 3AN: 161595Hom.: 0 AF XY: 0.0000197 AC XY: 1AN XY: 50675
GnomAD4 exome AF: 0.0000561 AC: 61AN: 1087639Hom.: 0 Cov.: 29 AF XY: 0.0000788 AC XY: 28AN XY: 355315
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.511G>A (p.V171I) alteration is located in exon 5 (coding exon 4) of the SYTL5 gene. This alteration results from a G to A substitution at nucleotide position 511, causing the valine (V) at amino acid position 171 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at